These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 5504550

  • 21. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W.
    Wien Med Wochenschr; 1971 Nov 13; 121(46):827-9. PubMed ID: 5138823
    [No Abstract] [Full Text] [Related]

  • 22. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F, Roth R, Ross P, Davis J.
    J Ky Med Assoc; 1971 Apr 13; 69(4):265-9. PubMed ID: 5577419
    [No Abstract] [Full Text] [Related]

  • 23. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A.
    Neurology; 1970 Apr 13; 20(4):377. PubMed ID: 5534982
    [No Abstract] [Full Text] [Related]

  • 24. [L-Dopa in the treatment of Parkinson's disease].
    Warot P.
    Lille Med; 1971 Apr 13; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract] [Full Text] [Related]

  • 25. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H.
    Ugeskr Laeger; 1969 May 29; 131(22):959-60. PubMed ID: 5793628
    [No Abstract] [Full Text] [Related]

  • 26. [One year of experience with L-Dopa in Parkinson's disease].
    Henry P, Lacut JY, Pouget-Abadie J, Bergouignan M, Leng-Lĕvy J.
    Bord Med; 1971 May 29; 4(5):1581-91. PubMed ID: 5569952
    [No Abstract] [Full Text] [Related]

  • 27. L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients).
    Fincham RW, Decker DA.
    J Iowa Med Soc; 1970 Nov 29; 60(11):755-9. PubMed ID: 5482403
    [No Abstract] [Full Text] [Related]

  • 28. L-dopa in parkinson's syndrome.
    Cotzias GC, Papavasiliou PS, Gellene R.
    N Engl J Med; 1969 Jul 31; 281(5):272. PubMed ID: 5791298
    [No Abstract] [Full Text] [Related]

  • 29. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA, Campanella G.
    Acta Neurol (Napoli); 1971 Jul 31; 26(1):46-60. PubMed ID: 5553941
    [No Abstract] [Full Text] [Related]

  • 30. [Pathomechanism and pharmacological treatment of Parkinson's disease].
    Pakszys W.
    Pol Tyg Lek; 1971 Jun 21; 26(25):965-7. PubMed ID: 4935461
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 32. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ, Elizan TS, Siegel G.
    Trans Am Neurol Assoc; 1970 Jun 07; 95():286-7. PubMed ID: 5514393
    [No Abstract] [Full Text] [Related]

  • 33. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
    Shibazaki H.
    Shinkei Kenkyu No Shimpo; 1971 Jun 07; 15(4):992-1002. PubMed ID: 4400830
    [No Abstract] [Full Text] [Related]

  • 34. [Serum gonadotropic level under the medication L-dopa].
    Janzik HH, Heller S.
    Arzneimittelforschung; 1974 Aug 07; 24(8):1084-5. PubMed ID: 4479602
    [No Abstract] [Full Text] [Related]

  • 35. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU, Stam FC, Meerlo HJ.
    Ned Tijdschr Geneeskd; 1971 Apr 17; 115(16):701-7. PubMed ID: 5551426
    [No Abstract] [Full Text] [Related]

  • 36. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU, Hoel RL, Lassman FM.
    Neurology; 1970 Apr 17; 20(4):410-1. PubMed ID: 5535064
    [No Abstract] [Full Text] [Related]

  • 37. [L-dopa effect in Parkinson's syndrome].
    Römer F, Bettag W, Bock WJ.
    Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715
    [No Abstract] [Full Text] [Related]

  • 38. [A contribution to the biochemical treatment of the akinetic type of the Parkinson's syndrome].
    Völler GW.
    Med Welt; 1968 Feb 03; 5():338-41. PubMed ID: 5668416
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G.
    Sist Nerv; 1970 Feb 03; 22(2):144-52. PubMed ID: 5504553
    [No Abstract] [Full Text] [Related]

  • 40. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2119. PubMed ID: 4773985
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.